J. Zhang, “FDX1 is a Potential Prognostic Biomarker Related to Cuproptosis and Immune Infiltration for Patients with Kidney Clear Cell Carcinoma”, Annals KEMU, vol. 30, no. 4, pp. 334–343, Dec. 2024.